28-Aug-2018 | Zion Market Research
Zion Market Research has published a new report titled “In Vivo Toxicology Market by Product (Instruments, Animal models, and Reagents & Kits), by Testing Type (Chronic Toxicity Testing, Sub-chronic Toxicity Testing, Sub-acute Toxicity Testing, and Acute Toxicity Testing), and by Toxicity Endpoints (Systemic Toxicity, Immunotoxicity, and DART): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024”. According to the report, global in vivo toxicology market was valued at approximately USD 4,163.55 million in 2017 and is expected to generate revenue of around USD 6,609.87 million by end of 2024, growing at a CAGR of around 6.84% between 2018 and 2024.
Toxicology is the domain of science that studies the adverse effects of chemicals and substances on living organisms and surroundings. Toxicology also includes diagnosis and treatment of exposure to toxins. In toxicology, dosage has a great importance and is directly linked to the effects experienced by the individuals.
Browse the full "In Vivo Toxicology Market by Product (Instruments, Animal models, and Reagents & Kits), by Testing Type (Chronic Toxicity Testing, Sub-chronic Toxicity Testing, Sub-acute Toxicity Testing, and Acute Toxicity Testing), and by Toxicity Endpoints (Systemic Toxicity, Immunotoxicity, and DART): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024" report at https://www.zionmarketresearch.com/report/in-vivo-toxicology-market
In vivo toxicological testing helps in understanding the biological responses of individuals to toxin exposure. During the development process of new drugs, in vivo toxicology helps in minimizing the adverse effects of molecules. Animal models are used to test the chemicals for toxicity. In vivo toxicology is also used to test the effects of toxic substances on the immune system. Studies are conducted on animals to observe the effects of industrial and environmental chemicals on the immune system.
The number of clinical trials is constantly on the rise. According to the ClinicalTrials.gov, a total of 281,305 studies are registered on their database as of August 2018. The U.S. Food and Drugs Administration approved 46 novel drugs in 2017. In recent years, regulatory authorities have introduced strict guidelines for animal testing. Pharmaceutical companies are required to conduct a complete study of the effects of molecules on living organisms.
In order to organize the toxicological profiles of new drugs, preclinical toxicology studies are absolutely necessary. In vivo toxicology tests are also necessary to set up the toxicological analysis of potentially harmful materials. In vivo toxicology testing helps in understanding the toxic effects of various materials on the organs. Animal models are used to study the effects of the harmful chemicals.
Factors such as rise in pharmaceutical research and development activities, compulsory animal testing regulations, and modernization of animal models will drive the growth of the global in vivo toxicology market. Moreover, the advancement of unique in vivo toxicology tests is expected to boost the global in vivo toxicology market. The surge in oncology research, increasing focus on the development of personalized medicine, and increasing demand for humanized animal models can act as a golden opportunity to the in vivo toxicology market. Nevertheless, drawbacks of animal testing and rising demand to develop and undertake substitute animal testing methods can restrict the growth of global in vivo toxicology market.
The global in vivo toxicology market is segmented into the product, testing type, toxicity endpoints, and region. The product segment is segmented into instruments, animal models, and reagents & kits. Animal models segment hold the maximum share of the product segment owing to rise in the development of genetically modified animals. Based on the testing type, the in vivo toxicology market is segmented into chronic toxicity testing, sub-chronic toxicity testing, sub-acute toxicity testing, and acute toxicity testing. Based on toxicity endpoints, the in vivo toxicology market is segmented into systemic toxicity, immunotoxicity, and DART.
North America, Asia Pacific, Europe, the Middle East & Africa, and Latin America are key regional segments of global in vivo toxicology market. North America is anticipated to remain the leading region over the forecast period followed by Europe. Demand for in vivo toxicology products was highest in North America especially in the U.S. Asia Pacific is expected to be the highest growing region in vivo toxicology market during the forecast period. Moreover, the Middle East & Africa and Latin America are also expected to show moderate growth for this market in the years to come.
Some of the key players in the market include Danaher, Charles River, Thermo Fisher, The Jackson Laboratory, and Covance, among others.
This report segments the global in vivo toxicology market as follows:
Global In Vivo Toxicology Market: By Product
Global In Vivo Toxicology Market: By Testing Type
Global In Vivo Toxicology Market: By Toxicity Endpoints
Global In Vivo Toxicology Market: By Region
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651